ehealth radio network
Episodes
Wednesday Dec 16, 2020
Wednesday Dec 16, 2020
Dr. Baljit Khamba, a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California joins eHealth Radio and the Health News Channel.
Bastyr University is a nonprofit, private university offering doctoral, graduate and undergraduate degrees, with a multidisciplinary curriculum in science-based natural medicine. Recognized globally for its rigorous curriculum and strong research, the 42-year-old University has campuses in Kenmore, Washington, and San Diego, California. Bastyr's international faculty educate future leaders in the natural health arts and sciences, with an emphasis on integrating mind, body, spirit and nature.
Listen to interview with host Eric Michaels and guest Dr. Baljit Khamba discuss the following:
Tell us how you and your colleagues came to this research idea.
What evidence did the research show that honey can be effective with respiratory illness?
Why is your immunity and respiratory health important right now?
How can you incorporate honey into your daily routine to support your immune system?
What are other ways people can boost their immune system?
Dr. Baljit Khamba is a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California. She treats a variety of conditions but has special interest in nutritional approaches to anxiety, stress, depression, focus and attention, memory and cognition. She focuses on providing high quality care addressing the causes of disease and utilizes safe and effective natural treatments. She accepts patients and their families who are motivated to improve their health. Her emphasis is on disease prevention and health promotion through education and empowering her patients to become active participant in the management of their own health.
While completing bachelor and master’s degrees, she worked as a research analyst at the Centre for Addiction and Mental Health (CAMH), where she researched alcohol addiction and anxiety, as well as nutrition and mental health. Dr. Khamba also has experience working in integrative psychiatric clinics, as well as more generalized practice, as well as being involved with research projects at the University of Alberta on natural health product safety in psychiatric patients. Dr. Khamba also maintains a private telemedicine practice.
Websites: https://bastyr.edu | https://bastyrclinic.org
Saturday Dec 12, 2020
Saturday Dec 12, 2020
Dr. Bob DeMaria, the Founder of The Drugless Doctors, a chiropractic practice in Cleveland, OH and Naples, FL that also provides personalized nutrition, drugless lab testing, and breast thermography joins eHealth Radio and the Chiropractor and Mental Health Channels.
Listen to interview with host Eric Michaels and guest Dr. Bob DeMaria discuss the following:
What is mental health?
Why is there such an emphasis on mental health today?
How can the food we consume affect our mental health?
How can someone improve mental health conditions like depression and anxiety naturally?
If someone wanted to begin a roadmap to improve their mental health today, what are the first three things they can do?
Dr. Bob DeMaria is an accomplished healthcare provider with over forty years experience helping individuals from all over the world without ever prescribing a single medication. His educational background includes a degree in Human Biology, specialties in Spinal Engineering and Natural Orthopedic Treatments, valedictorian of his chiropractic class at National University of Health Sciences, and an NHD degree.
He is the founder of The Drugless Doctors, a chiropractic and nutrition-based practice, with locations in Cleveland, Ohio and Naples, Florida. His extensive research and clinical observations have been the foundation for his eleven books, including the new, “Dr. Bob’s Drugless Guide to Mental Health,” which he co-wrote with his wife, Debbie.
An avid fan of life after 5pm, Dr. Bob enjoys riding his bicycle, playing bocce, and celebrating any occasion with his family.
Website: druglessdoctor.com
Social Media Links: Instagram: instagram.com/druglessdoctor Facebook: facebook.com/druglessdoctor Twitter: twitter.com/druglessdoctor
Friday Dec 11, 2020
Friday Dec 11, 2020
Tony Giordano, PhD and Chief Scientific Officer of JanOne (NASDAQ: JAN), which is focused on developing treatments for diseases that cause severe pain joins eHealth Radio and and the Health News and Pain Management Channels.
Listen to interview with host Eric Michaels and guest Tony Giordano, PhD discuss the following:
Can you tell me a bit about yourself and how you got interested in reducing the need for opioid prescriptions that led to your involvement with JanOne?
Please give us an overview of JAN101 and its recent developments.
It is estimated that 40% of opioid overdose deaths involve prescription opioids, how is JanOne tackling the issue?
What is Jan’s main focus when treating diseases that cause pain to millions around the world?
Could you please give us some insight on Jan’s treatment for PAD and how PAD can affect patients?
JanOne (NASDAQ: JAN) is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease-associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021. JanOne is dedicated to funding resources toward innovation, technology, and education for PAD, associated vascular conditions and neuropathic pain. JanOne continues to operate its legacy businesses under their current brand names, which are undergoing review to determine appropriate strategic alternatives
Website: https://janone.com
Social Media Links: Facebook: facebook.com/JanOneOfficial Linkedin: linkedin.com/company/janone Twitter: twitter.com/JanOne
Tuesday Dec 08, 2020
Tuesday Dec 08, 2020
Rodney Varner, the CEO of Genprex, a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes joins eHealth Radio and the Cancer Information Diabetes and Health News Channels.
Listen to interview with host Eric Michaels and guest Rodney Varner discuss the following:
What inspires you at Genprex?
Please give us an overview of Genprex’s gene therapies in development. What is it intended to treat, and how does it work?
Could you talk more specifically about Genprex’s lead product candidate GPX-001?
Could you please give us some insight about GPX-002, gene therapy for people with diabetes and what is it comprised of?
What are the benefits of Genprex’s targeted therapies for people with non-small cell lung cancer?
Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
Website: genprex.com
Social Media Links: Facebook: facebook.com/genprexinc Linkedin: linkedin.com/company/genprex Twitter: twitter.com/genprex
Saturday Dec 05, 2020
Saturday Dec 05, 2020
Myron Holubiak, President and CEO of Citius Pharmaceuticals, and Leonard Mazur, Chairman of the Board at Citius Pharmaceuticals, a specialty late-stage pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives and cancer care joins eHealth Radio and the Cancer Information and Health News Channels.
Listen to interview with host Eric Michaels and guests Myron Holubiak & Leonard Mazur discuss the following:
Please give us an overview of catheter-related bloodstream infections (CRBSIs) and central venous catheters (CVCs).
Who is at Risk for Catheter-Related Bloodstream Infections (CRBSIs)?
Please give us a brief description of Minolok and how does it help the standard of care in the management of CRBSIs?
Give us a brief description of our NoveCite subsidiary and the impact of Covid 19 patients w ARDS. What is your technology and why is it different?
How is the development of MinoWrap for mastectomies progressing after your collaboration w MD Andersen?
Why did the both of you invest 26.5 million into the company?
Mr. Mazur is an accomplished entrepreneur and pharmaceutical industry executive with notable accomplishments in founding, building and creating value and returns for investors. Mr. Mazur was the Chairman of Leonard Meron Biosciences, Inc. prior to its merger with Citius in March 2016. He is the cofounder and Vice Chairman of Akrimax Pharmaceuticals, LLC (“Akrimax”), a privately held pharmaceutical company specializing in producing cardiovascular and general pharmaceutical products. Akrimax was founded in September 2008, and has successfully launched prescription drugs while acquiring drugs from major pharmaceutical companies. From January 2005 to May 2012, Mr. Mazur also co-founded and served as the Chief Operating Officer of Triax Pharmaceuticals LLC (“Triax”), a specialty pharmaceutical company producing prescription dermatological drugs. Prior to joining Triax, he was the founder, and, from 1995 to 2005, Chief Executive Officer, of Genesis Pharmaceuticals, Inc. (“Genesis”), a dermatological products company that marketed its products through dermatologists’ offices, and co-promoted products for major pharmaceutical companies. In 2003, Mr. Mazur successfully sold Genesis to Pierre Fabre, a leading pharmaceutical company.
Mr. Mazur has extensive sales, marketing and business development experience from his tenures at Medicis Pharmaceutical Corporation, as Executive Vice President, ICN Pharmaceuticals, Inc., as Vice President, Sales & Marketing, Knoll Pharma (a division of BASF), and Cooper Laboratories, Inc.
Mr. Mazur is a member of the Board of Trustees of Manor College, and is a recipient of the Ellis Island Medal of Honor. Mr. Mazur received both his BA and MBA from Temple University, and has served in the US Marine Corps Reserves.
Mr. Holubiak has extensive experience in managing and leading both large and emerging pharmaceutical and life sciences companies. Mr. Holubiak was co-founder, director and CEO of Leonard Meron Biosciences, Inc. prior to its merger with Citius in March 2016. Mr. Holubiak was the President of Roche Laboratories, Inc. (“Roche”), a major research-based pharmaceutical company, from December 1998 to August 2001.
Prior to that, he held sales and marketing positions at Roche during his 19-year tenure there. As President of Roche, Mr. Holubiak helped transform Roche Labs into a leading antibiotic and biotechnology company. He was also founder of Emron, Inc., a health economics and managed care consulting company, and helped to create the Academy of Managed Care Pharmacy (AMCP). Mr. Holubiak was also a director of Bioscrip, Inc., a national home infusion company, from 2002 through 2016, and served as its Chairman of the Board from 2012 through 2016.
Since July 2010, Mr. Holubiak has served as a member of the Board of Directors of Assembly Biosciences, Inc. (“Assembly”) and its predecessor, Ventrus Biosciences, Inc. Mr. Holubiak is also a trustee of the Academy of Managed Care Pharmacy Foundation. He received a BS in Molecular Biology and Biophysics from the University of Pittsburgh; he received advanced business training from the Harvard Business School and the University of London, as well as advanced training in health economics from the University of York’s Centre for Health Economics.
Website: citiuspharma.com
Friday Dec 04, 2020
Friday Dec 04, 2020
Dr. Joseph DeSanto, an Addiction Specialist with BioCorRx Inc., an addiction treatment solutions company targeting substance use and other related disorders joins eHealth Radio and the Addiction Prevention and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Joseph DeSanto discuss the following:
How has COVID-19 exasperated the US opioid crisis?
What added factors may cause addicts to relapse during the pandemic?
How has telehealth helped serve the addiction recovery community? Can you tell me how BioCorRx uses telehealth?
What makes the Beat Addiction Recovery Program unique?
With the winter holidays approaching, why are addicts more likely to relapse?
How can family members help loved ones get help and navigate their addiction during these unprecedented times?
Dr. Joseph DeSanto is a Board Certified Addictionologist for DeSanto Clinics and addiction specialist with addiction treatment solutions company, BioCorRx. He has more than 12 years of experience practicing medicine, is a graduate of Lafayette College and attended the State University of New York at Downstate in Brooklyn for his medical school training. He completed his internship and residency training at Cedars Sinai Medical Center in Los Angeles and is Board Certified by the American Board of Internal Medicine. In addition to his role with BioCorRx, he serves as a medical consultant for a number of treatment centers in Orange County, CA.
Website: BeatAddiction.com
Social Media Links: Twitter: twitter.com/biocorrxinc Facebook: facebook.com/BioCorRx
Thursday Dec 03, 2020
Thursday Dec 03, 2020
Daniel Zakowski, the CEO and co-founder at Ready, Set, Food! - an innovative company that is working to help prevent babies from developing severe food allergies joins eHealth Radio and the Allergy Information & Health News Channels. Daniel even was on the hit show Shark Tank, where he got investor Mark Cuban to join the RSF team!
Listen to interview with host Eric Michaels and guest Daniel Zakowski discuss the following:
How did you come up with the Ready, Set, Food! product and concept?
What are the health benefits to kids taking it daily?
What is the recommended daily dosage?
For parents that may be worried about adding this to their infants bottles, what have the results been like?
Your product is partnering with hospitals and organizations around the US. Tell us more about what's to come!
Ready, Set, Food! is the first to introduce a system that is safe and easy for parents to gently introduce products to babies via powder packets that get added to a baby's bottle or food. The company has already helped reduce the risk of food allergies in kids by 80% and helped prevent over 200,000 babies across the US from developing those severe food allergies.
Website: readysetfood.com
Social Media Links: Instagram: instagram.com/readysetfood Facebook: facebook.com/readysetfood
Wednesday Dec 02, 2020
Wednesday Dec 02, 2020
Dr. Jason Levine, Clinical Psychologist in private practice in Los Angeles that specializes in Substance Use Disorders, Anxiety, Depression, LGBTQ+ issues, and anger management joins eHealth Radio and the Mental Health & Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Jason Levine discuss the following:
How has the pandemic impacted people with previous mental health or substance abuse challenges?
What are some things people can do to lessen their anxiety or depression?
What is the CBT Model of treatment?
What do you see as challenges ahead as the pandemic numbers increase and there is uncertainty around when things will get better?
How can loved ones get involved if they see issues developing with someone in their family?
Dr. Levine is a licensed Clinical Psychologist born, raised, and clinically trained in New York. He has held a number of leadership positions throughout the years and is currently in private practice in Los Angeles, CA. His most recent position was as Senior Executive Director of Promises Treatment Centers in Malibu.
Dr. Levine offers expert treatment for those who seek a caring and highly experienced treatment provider. He offers highly individualized cognitive behavioral and psychodynamic treatment in his specialty areas of substance use, anxiety and depression, LGBTQ+, persons with HIV/AIDS, anger management and smoking cessation treatment. Dr. Levine has been trained at the Mayo Clinic in their Tobacco Specialist Training Program to provide expert vaping, chew and smoking cessation services.
Dr. Levine received his doctorate from the New School for Social Research in New York City and has since been providing clinical treatment and administrative oversight to a myriad of cutting-edge programs for over 25 years. Dr. Levine has always made it his priority to implement the most innovative treatment solutions for the most challenging issues.
Dr. Levine can be reached at: levinephd@gmail.com.
Website: www.jasonlevinephd.com
Social Media Links: Instagram: instagram.com/levinephd Facebook: facebook.com/jasonlevinepsychologist
The beliefs, views, ideas, thoughts and opinions expressed on any program are those of the persons appearing on the program and do not necessarily reflect the views and opinions of the eHealth Radio Network.
Saturday Nov 28, 2020
Saturday Nov 28, 2020
Dr. Douglas S. Harrington, MD Fellow of the American Society of Preventive Cardiology, and the American Society of Clinical Pathology, who is an expert in laboratory diagnostic testing joins eHealth Radio and the Health Care and Health News Channels. Dr. Harrington is also the Chairman of the GUARDaHEART Foundation 501(c)3 who is actively partnering with community organizations, nonprofit organizations, businesses, and city officials to provide the community with No-Cost COVID-19 Antibody Tests covered under the CARES Act.
Listen to interview with host Eric Michaels and guest Dr. Douglas S. Harrington discuss the following:
What is GUARDaHEART Foundation’s goal in partnering with the community to provide the SARS-CoV-2 Antibody Test?
What is the difference between a COVID-19 swab test vs and COVID-19 SARS-CoV-2 antibody test?
Who should take the antibody test and what are the benefits of having the test?
What is the difference between IgG and IgM antibodies and how long does it take to develop antibodies?
How long do the antibodies stay in my body?
If my antibody report results positive, am I immune to COVID-19?
What happens if someone tests positive for the COVID-19 Antibodies? Should they be quarantined?
Is it true that the Latin Community and African American Community have the highest rates of COVID? If so, why is that?
What is the correlation of heart disease and coronavirus?
Tell us about the SARS-CoV-2 serology antibody test being provided with a sensitivity of 100% and a specificity of 99.6% based on initial performance evaluations. Is this more reliable than other tests being provided?
Are there natural medicines that aim to help to reduce an individual from getting the virus?
Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. Heco-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma StudyGroup headed by Dr. Jim Armitage. As President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology,cytogenetic, and anatomic pathology offerings. Dr. Harrington led the team that developed one of the first digital microscopes targeted at minimal residual disease and circulating tumor cells as the founder and CEO of Clarient. Dr.Harrington also led the turnaround and reinstatement of theFederal license of Specialty Laboratories, a New York StockExchange company, as CEO and Laboratory Director.
Dr. Harrington has developed patents for an automated method for image analysis of residual cancer cells, a patent covering catalytic heavy metal extraction, and a patent pending on biomarker assay for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies - from devices to molecular genetics focusing on immunology, cancer and cardiology,where he has taken a number of new molecular technologies through state and federal regulatory approval, and has been involved in the commercialization of over 200 academic discoveries. He is a member of Phi Beta Kappa, the nation’s most prestigious academic honor society.
Dr. Harrington is the inventor of the PULS Cardiac Test (TM) ,a breakthrough blood test for the detection of the leading cause of heart attacks, and CEO & Laboratory Director ofGlobal Discovery Biosciences. Throughout his career Dr.Harrington has remained a Clinical Professor of Pathology at the USC Keck School of medicine, a published author of numerous peer-reviewed papers, and a sought after speaker in the area of preventive medicine and technology development. Dr. Harrington received his BA in molecular biology, his MD from the University of Colorado HealthSciences Center, and is a board-certified in hematology,anatomic and clinical pathology.
Website: www.guardaheart.org
Social Media Links: Facebook: facebook.com/Guardaheartfoundation Twitter: twitter.com/guardaheartorg
Saturday Nov 21, 2020
Saturday Nov 21, 2020
Regan Jones, a registered dietitian nutritionist who’s been working in social media and recipe development with Cabot Creamery for more than a decade joins eHealth Radio and the Health News and the Nutrition Channels.
Listen to interview with host Eric Michaels and guest Regan Jones discuss the following:
Tell us more about National Coop Month (which was last month in October) and how that ties into budget friendly meal planning?
When we think of planning budget friendly meals, we often think of “cutting back”... which sounds like cutting back on the flavor and enjoyment of meal time. How can we keep meals tasting great while still watching our budget?
What tips can you give us about shopping for budget friendly meals?
Other than visiting your website for recipes, what other advice can you give us about finding budget friendly recipes to cook for our families?
People are sometimes reluctant to buy less expensive frozen or canned produce out of concern that it’s less nutritious. Is it?
What’s the one thing you want to leave listeners with that will help them with budget friendly meal planning?
Regan Jones is a nationally-known, award-winning registered dietitian nutritionist. She has more than 20+ years of experience sharing quick & easy solutions for healthy living, including roles as a former assistant food editor at Weight Watcher's and Cooking Light Magazines and as a spokesperson for Cabot Creamery Cooperative for more than a decade.
Regan's recipes and nutrition insights are frequently featured in the national media. In 2017 she was awarded the prestigious Academy of Nutrition and Dietetics Media Excellence Award.
An age 40+ mom to two boys, Jones has been blazing trails as a women entrepreneur for more than a decade, and is currently the host of the iTunes Top 25 Personal Journal Podcast, This Unmillennial Life.
Website: www.cabotcheese.coop
Social Media Links: Instagram: instagram.com/cabotcheese Linkedin: linkedin.com/company/cabot-creamery Facebook: facebook.com/cabot Twitter: witter.com/cabotcheese